KR102769007B1 - 대장암 및/또는 이의 전암 단계 진단을 위한 단백질 시그니처 - Google Patents

대장암 및/또는 이의 전암 단계 진단을 위한 단백질 시그니처 Download PDF

Info

Publication number
KR102769007B1
KR102769007B1 KR1020217031563A KR20217031563A KR102769007B1 KR 102769007 B1 KR102769007 B1 KR 102769007B1 KR 1020217031563 A KR1020217031563 A KR 1020217031563A KR 20217031563 A KR20217031563 A KR 20217031563A KR 102769007 B1 KR102769007 B1 KR 102769007B1
Authority
KR
South Korea
Prior art keywords
cyfra21
areg
flt3l
clec2c
erbb4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217031563A
Other languages
English (en)
Korean (ko)
Other versions
KR20210134946A (ko
Inventor
로드리게즈 안나 카르멘 마르틴
팔라시오스 로사 페레즈
아렌즈 로시오 아로요
Original Assignee
어드밴스드 마커 디스커버리 에스.엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 어드밴스드 마커 디스커버리 에스.엘. filed Critical 어드밴스드 마커 디스커버리 에스.엘.
Publication of KR20210134946A publication Critical patent/KR20210134946A/ko
Application granted granted Critical
Publication of KR102769007B1 publication Critical patent/KR102769007B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G01N33/57419—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • G01N33/57484—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020217031563A 2019-03-01 2020-02-28 대장암 및/또는 이의 전암 단계 진단을 위한 단백질 시그니처 Active KR102769007B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19382157.6 2019-03-01
EP19382157 2019-03-01
EP19382156 2019-03-01
EP19382156.8 2019-03-01
PCT/EP2020/055277 WO2020178172A1 (en) 2019-03-01 2020-02-28 Protein signature for the diagnosis of colorectal cancer and/or pre-cancerous stage thereof

Publications (2)

Publication Number Publication Date
KR20210134946A KR20210134946A (ko) 2021-11-11
KR102769007B1 true KR102769007B1 (ko) 2025-02-14

Family

ID=69631636

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217031563A Active KR102769007B1 (ko) 2019-03-01 2020-02-28 대장암 및/또는 이의 전암 단계 진단을 위한 단백질 시그니처

Country Status (10)

Country Link
US (1) US20220276249A1 (https=)
EP (1) EP3931571B1 (https=)
JP (2) JP2022522803A (https=)
KR (1) KR102769007B1 (https=)
CN (1) CN113785199B (https=)
AU (1) AU2020230963B2 (https=)
CA (1) CA3131729A1 (https=)
ES (1) ES2952139T3 (https=)
MX (1) MX2021010451A (https=)
WO (1) WO2020178172A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2952139T3 (es) * 2019-03-01 2023-10-27 Advanced Marker Discovery S L Firma proteica para el diagnóstico de cáncer colorrectal y/o etapa precancerosa del mismo
WO2021185982A1 (en) * 2020-03-19 2021-09-23 Advanced Marker Discovery S.l. Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof
CA3202255A1 (en) 2020-12-21 2022-06-30 Hayley WARSINSKE Markers for the early detection of colon cell proliferative disorders
KR102900859B1 (ko) * 2021-12-31 2025-12-17 주식회사 이노제닉스 대장암 및 대장 용종 또는 진행 선종의 선별 방법 및 그 응용

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008522172A (ja) * 2004-12-23 2008-06-26 エフ．ホフマン−ラ ロシュ アーゲー 直腸結腸癌用マーカーとしてのｃｙｆｒａ２１−１の使用
US20140220006A1 (en) 2013-02-01 2014-08-07 Meso Scale Technologies, Llc Lung cancer biomarkers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101896817A (zh) * 2007-12-10 2010-11-24 霍夫曼-拉罗奇有限公司 用于结直肠癌的标记物组
CN103140760B (zh) * 2010-07-14 2016-01-27 联邦科学与工业研究组织 结肠直肠癌的诊断
US20160291025A1 (en) * 2013-09-18 2016-10-06 Adelaide Research & Innovation Pty Ltd Autoantibody biomarkers of ovarian cancer
JP6339399B2 (ja) * 2014-03-28 2018-06-06 学校法人北里研究所 卵巣明細胞腺癌細胞の検出方法、卵巣明細胞腺癌診断薬、卵巣明細胞腺癌診断用プライマー、卵巣明細胞腺癌診断用キット、及び卵巣明細胞腺癌診断用プローブ
EP3073268A1 (en) * 2015-03-27 2016-09-28 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Biomarker panel for diagnosing cancer
JP2018136122A (ja) * 2015-05-29 2018-08-30 国立研究開発法人国立がん研究センター 膵がんを診断するための血漿バイオマーカーパネル
US20180160885A1 (en) * 2016-12-13 2018-06-14 Prosper Abitbol Endoscopy based medical devices, methods, and innovations
KR102018205B1 (ko) * 2017-07-24 2019-09-05 (주) 바이오인프라생명과학 대장암 진단용 조성물 및 상기 조성물을 이용한 대장암 진단 방법
US10968583B2 (en) * 2017-07-26 2021-04-06 David E. Lambert Reflective road marker
ES2952139T3 (es) * 2019-03-01 2023-10-27 Advanced Marker Discovery S L Firma proteica para el diagnóstico de cáncer colorrectal y/o etapa precancerosa del mismo
WO2021185982A1 (en) * 2020-03-19 2021-09-23 Advanced Marker Discovery S.l. Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008522172A (ja) * 2004-12-23 2008-06-26 エフ．ホフマン−ラ ロシュ アーゲー 直腸結腸癌用マーカーとしてのｃｙｆｒａ２１−１の使用
US20140220006A1 (en) 2013-02-01 2014-08-07 Meso Scale Technologies, Llc Lung cancer biomarkers

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Chen Hongda et al, Journal of Clinical Epidemiology (2016.2.2.), vol 75, pp 108-114.
H Chen et al, Clinical Cancer Research (2015.5.26.), vol 21, no 4, pp 3318-3326.
Hongda Chen et al, Clinical Epidemiology (2017.10.1.), vol 9, pp 517-526.
Qian Jing et al, (2018.8.1.), vol 104, pp 24-34.

Also Published As

Publication number Publication date
US20220276249A1 (en) 2022-09-01
AU2020230963A1 (en) 2021-09-30
CN113785199A (zh) 2021-12-10
EP3931571B1 (en) 2023-06-07
JP2022522803A (ja) 2022-04-20
BR112021017248A2 (pt) 2021-11-09
EP3931571C0 (en) 2023-06-07
ES2952139T3 (es) 2023-10-27
CA3131729A1 (en) 2020-09-10
JP2025038186A (ja) 2025-03-18
WO2020178172A1 (en) 2020-09-10
EP3931571A1 (en) 2022-01-05
KR20210134946A (ko) 2021-11-11
AU2020230963B2 (en) 2026-03-12
MX2021010451A (es) 2021-12-10
CN113785199B (zh) 2024-02-09

Similar Documents

Publication Publication Date Title
KR102769007B1 (ko) 대장암 및/또는 이의 전암 단계 진단을 위한 단백질 시그니처
US11193935B2 (en) Compositions, methods and kits for diagnosis of lung cancer
EP3885768A1 (en) Biomarker panel for diagnosing cancer
KR102061441B1 (ko) 폐 질환의 동정, 평가, 예방 및 치료 방법과, 성별에 기초하는 질환의 동정, 평가, 예방 및 치료를 포함하는 상기 방법의 키트
CN118465282A (zh) 预测结直肠癌肝转移的生物标志物组合、试剂盒、系统及其应用
Yang et al. Clinical utility of six serum tumor markers for the diagnosis of lung cancer
TWI522367B (zh) Urine biomarkers are used to predict bladder and kidney cancer
WO2015042454A1 (en) Compositions, methods and kits for diagnosis of lung cancer
US20230204584A1 (en) Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof
CN119757585A (zh) 一种基于蛋白质组学诊断结直肠癌的产品及应用
CN118687953A (zh) 用于进展期腺瘤检测的生物标志物及其应用
RU2830580C2 (ru) Белковая сигнатура для диагностики колоректального рака или его предраковой стадии
CN117741150A (zh) 一种用于检测肺癌的组合标志物、试剂盒及其用途
CN114674969A (zh) 尿液中生物标志物检测试剂在制备新冠肺炎诊断试剂盒中的用途
CN111583994A (zh) 肿瘤标志物截断值联合模型及其应用
WO2020013097A1 (ja) 前立腺がんに特異的な糖鎖、及びこれを用いた検査方法
BR112021017248B1 (pt) Método in vitro para o diagnóstico de câncer colorretal e/ou um seu estágio pré- canceroso, usos in vitro da combinação de [flt3l e cyfra21-1] e da combinação de da combinação de [flt3l e cyfra21-1 e areg], ou [flt3l e cyfra21-1 e areg e erbb4], ou {flt3l e cyfra21-1 e areg e clec2c] em uma amostra biológica obtida do paciente,e uso de um kit de partes
CN120369969A (zh) 一种用于区分肺癌和肺炎的生物标志物及其应用
Mohamed et al. Assessment of Serum Levels of Insulin Like Growth Factor 1 in Patients with Colorectal Cancer
US20220091140A1 (en) Method of diagnosis
WO2026068798A1 (en) Sox9 for assessing colorectal cancer (crc) or a precancerous condition thereof
CN120405156A (zh) 一种用于肺癌分型的血清蛋白生物标志物及其应用
CN118604342A (zh) 一种胃癌检测标记物组合及其应用
CN117169504A (zh) 用于胃癌相关参数检测的生物标志物及相关预测系统及应用
Chen et al. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of non-small cell lung cancer 2

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R17-X000 Change to representative recorded

St.27 status event code: A-5-5-R10-R17-oth-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000